Risks for multidrug-resistant pathogens in the ICU
Ignacio Martín-Loeches1, Emili Diaz, Jordi Vallés
1aMultidisciplinary Intensive Care Research Organization, Trinity Centre for Health Sciences, St. James's Hospital, Dublin, Ireland bCorporació Sanitária I Universitaria Parc Taulí - Hospital De Sabadell, Institut Universitari UAB, Ciber Enfermedades Respiratorias, Sabadell, Barcelona, Spain.
Purpose Of Review:
The impact of multidrug-resistant organisms (MDROs) is rising and often underestimated. The epidemiology of MDROs is extremely complex and multifactorial. There is increasing antibiotic resistance, mainly related to antibiotic pressure and patients' characteristics.
Recent Findings:
Emphasis on MDRO epidemiology is needed to better understand current strategies of prevention and management. Among them, antibiotic stewardship has been one of the most successful strategies. It is important to note that there is a controversial issue when considering community and healthcare-related infections. In addition, different strategies have been determined to find the impact and optimal use of recently launched antibiotics for MDRO treatment.
Summary:
Infections with MDROs can prolong hospital stay, promote antibiotic use and prolong duration of mechanical ventilation. Some points should be further explored in clinical research such as the heterogeneity of healthcare-associated pneumonia and the need of new drug development. Resistance to non fermentative Gram-negative bacilli, rising minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus and spread of MDROs in patients without known risk factors suggest a review of guideline validation, taking into account ecology and severity of patient illness to provide timely and appropriate empiric therapy.
Insights
Multidrug-resistant organisms (MDROs) present a growing challenge due to complex epidemiology and increasing antibiotic resistance. Understanding MDRO spread and optimizing treatment strategies are crucial for effective prevention and management.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- The increasing prevalence and underestimated impact of multidrug-resistant organisms (MDROs) pose a significant global health threat.
- MDRO epidemiology is complex, driven by factors including antibiotic pressure and patient characteristics, leading to rising antibiotic resistance.
Purpose of the Study:
- To review the epidemiology of MDROs and discuss current prevention and management strategies.
- To highlight the importance of antibiotic stewardship and explore challenges in treating community- and healthcare-associated infections.
- To examine the impact and optimal use of new antibiotics for MDRO infections.
Main Methods:
- Literature review focusing on MDRO epidemiology and resistance patterns.
- Analysis of current antibiotic stewardship programs and their effectiveness.
- Evaluation of strategies for the clinical application of novel antimicrobial agents.
Main Results:
- Antibiotic stewardship is a key strategy in managing MDROs, though controversies exist regarding community versus healthcare-associated infections.
- Newer antibiotics are being developed, but their optimal use and impact require further investigation.
- MDRO infections are associated with prolonged hospital stays and increased healthcare resource utilization.
Conclusions:
- Further research is needed on healthcare-associated pneumonia heterogeneity and novel drug development for MDROs.
- Current guidelines may require revision to account for evolving MDRO ecology, patient severity, and resistance trends.
- Timely and appropriate empiric therapy is essential, necessitating a comprehensive understanding of local resistance patterns and patient factors.
Related Concept Videos
07:29Dosage-Adjusted Resistance Training in Mice with a Reduced Risk of Muscle Damage
06:04Objective Nociceptive Assessment in Ventilated ICU Patients: A Feasibility Study Using Pupillometry and the Nociceptive Flexion Reflex
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
19:15Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
10:43Expression, Detergent Solubilization, and Purification of a Membrane Transporter, the MexB Multidrug Resistance Protein
23:06The MODS method for diagnosis of tuberculosis and multidrug resistant tuberculosis